
Home Chapter Home Jobs Conferences Fellowships Books
Advertisement
Breast-nonmalignant
Benign tumors / changes
Papilloma of breast
Reviewer: Hind Nassar, M.D. in January 2009 (see Authors page)
Revised: 16 April 2010, last major update April 2010
Copyright: (c) 2002-2010, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Intraductal proliferation of epithelial and myoepithelial cells overlying fibrovascular stalks
Terminology
=========================================================================
● “Papillomatosis” is a confusing term because it may refer to hyperplasia or multiple papillomas
Epidemiology
=========================================================================
● Common; mean age 48 years
Sites
=========================================================================
●
Etiology
=========================================================================
● Arises from large or small ducts (arising from terminal duct lobular unit)
● May be related to ductal adenoma
Clinical features
=========================================================================
● Central or peripheral
● Central (large duct): close to nipple within principal lactiferous ducts, 90% solitary, 70% associated with nipple discharge; usually ages 30-49 years but any age
● Peripheral: often clinically occult, discovered by mammographic calcifications
● Single papillomas: no increased risk of subsequent malignancy with or without associated ADH/ALH (Am J Surg Pathol 2006;30:665), although in one study, 16% contained carcinoma (Eur J Surg Oncol 2010;36:384)
● Multiple papillomas: increased risk of subsequent malignancy, particularly if ADH/ALH is present (Am J Surg Pathol 2006;30:665)
- 5 or more papillomas are associated with coexisting atypical (ALH/LCIS, ADH) or malignant breast lesions, also recurrence and contralateral disease (Hum Pathol 2003;34:234)
● Atypical papillomas: distinction from papillary DCIS is based on size of atypical area or % of papilloma
- 4x increased risk of invasive carcinoma compared to papillomas without atypia, usually near site of original papilloma (Cancer 1996;78:258
Prognostic factors
=========================================================================
●
Case reports
=========================================================================
● 47 year old woman with coexisting breast and sentinel node papillomas (Am J Surg Pathol 2008;32:784)
● 57 year old man on long-term phenothiazines (Breast Cancer 2006;13:84)
● Associated with Costella syndrome (Cir Esp 2007;81:345)
Treatment
=========================================================================
● Local excision or microdochectomy (removal of breast duct)
● Core biopsy diagnosis of papilloma even without ADH probably requires excision (Ann Surg Oncol 2008;15:2272, Am J Surg Pathol 2002;26:1095, Eur J Surg Oncol 2008;34:1304, AJR Am J Roentgenol 2006;186:1328, Cancer 2009;115:2837), but see Am J Clin Path 2004;122:440, Am J Clin Path 2004;122:217 (no need for excision if no atypia)
Clinical images
=========================================================================
●
Gross description (Macroscopy)
=========================================================================
● Well circumscribed, polypoid intraductal mass, usually < 3 cm, soft, hemorrhagic
● Often infarcted
Gross images
=========================================================================
Polypoid intraductal mass
Other: hemorrhagic cyst with tan tumor
Micro description (Histopathology)
=========================================================================
● Multiple papillae in complex arborizing pattern with well-developed vascular connective tissue core surrounded by epithelial and myoepithelial cells
● Benign nuclei, frequent apocrine metaplasia, inflammation
● May arise within a large cystic duct, have comedo-type necrosis without DCIS (Ann Diagn Pathol 2004;8:276), rarely sebaceous metaplasia (Virchows Arch 2001;438:505)
● Infracted cases may have squamous metaplasia or appear pseudoinfiltrative due to fibrosis (Hum Pathol 1984;15:764)
● Fibrosis at edge of papillomas may entraps glands and resemble invasion (Semin Diagn Pathol 2010;27:13)
● Glandular proliferation within stalks may resemble cribriform DCIS
● Needle biopsies can deposit clusters of benign cells in a distribution that resembles invasive carcinoma
Micro images
=========================================================================
Various images
Dilated ducts containing connective tissue cores with multiple fingerlike projections
Multiple nodules and stromal fibrosis
Epithelial and myoepithelial cells
Stromal fibrosis resembles invasion
Central papilloma Papilloma with florid ductal hyperplasia
Encysted papilloma Peripheral papilloma Within lymph node
with hyperplasia
Apocrine intraductal papilloma with large nuclei and prominent nucleoli
Solid type
Fusion of adjacent papillae
creates gland-like spaces
Resembles sclerosing Infarcted papilloma
adenosis
With fibroblasts, fibrosis Small ducts surrounded by
and chronic inflammatory hyalinized fibrous tissue
infiltrate
Squamous metaplasia
With spindle cells Vessels but not spindle
cells are actin+
Atypia/malignancy Papilloma with atypia Papilloma with separate focus of ADH
Papilloma with severe atypia With micropapillary DCIS
With LCIS spreading in a pagetoid manner beneath ductal epithelium (plaque-like pattern)
Various images p63 Smooth muscle CD10 and smooth
actin muscle actin
Virtual Slides
=========================================================================
Intraductal papilloma
Peripheral papillomas and usual ductal hyperplasia
Videos
=========================================================================
Cytology description
=========================================================================
● High positive predictive value (Diagn Cytopathol 2006;34:818)
● Infarcted papillomas - early stages show numerous degenerated cells with smudged nuclei, ghost cells and necrotic debris; late stages show clusters of fibroblasts, ductal cells and necrotic debris (Diagn Cytopathol 2006;34:373)
Cytology images
=========================================================================
Positive stains
=========================================================================
● Epithelium: CK 5/6, CK14, 34betaE12 (Virchows Arch 2007;450:539); also CD44s (J Clin Pathol 1999;52:862)
● Myoepithelium: actin, S100, p63 (Am J Surg Pathol 2001;25:1054), calponin, smooth muscle myosin heavy chain (Am J Clin Path 2005;123:36), CD10 (Mod Pathol 2002;15:397)
Negative stains
=========================================================================
●
Electron microscopy descriptions
=========================================================================
●
Electron microscopy images
=========================================================================
Molecular / cytogenetics description
=========================================================================
● Clonal
Molecular / cytogenetics images
=========================================================================
Differential Diagnosis
=========================================================================
● Papillary DCIS: delicate or absent fibrovascular core, often atypical nuclei or atypical mitotic figures, pseudostratification, usually no apocrine metaplasia; other DCIS may be present, 71% have no/incomplete myoepithelal layer, 76% are 34betaE12 negative, 67% are positive for neuroendocrine markers (Virchows Arch 2007;450:539)
● Invasive papillary carcinoma: invasion into stroma, no myoepithelial layer
Additional references
=========================================================================
●
End of Breast-nonmalignant > Benign tumors / changes > Papilloma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).